---
title: "Quince Therapeutics, Inc. (QNCX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/QNCX.US.md"
symbol: "QNCX.US"
name: "Quince Therapeutics, Inc."
industry: "Biotechnology"
---

# Quince Therapeutics, Inc. (QNCX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.quincetx.com](https://www.quincetx.com) |

## Company Profile

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.20 | 97/605 | - | - | - |
| PB | 10.52 | 373/605 | 91.30 | 7.19 | 1.84 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-04T05:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 3 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.18 |
| Highest Target | 10.00 |
| Lowest Target | 5.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/QNCX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/QNCX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/QNCX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.